Relmada Therapeutics, Inc. Common Stock RLMD
$4.59
+0.22%
at last close
Recent SEC Filings
| Form | Description | Filed | Document |
|---|---|---|---|
| 8-K | CURRENT REPORT | 2026-08-06 | View → |
| 10-Q | QUARTERLY REPORT | 2026-08-06 | View → |
| 8-K | CURRENT REPORT | 2026-07-28 | View → |
| 8-K | CURRENT REPORT | 2026-05-28 | View → |
| 8-K | CURRENT REPORT | 2026-05-12 | View → |
| 10-Q | QUARTERLY REPORT | 2026-05-12 | View → |
| DEF 14A | PROXY STATEMENT | 2026-04-17 | View → |
| S-3 | REGISTRATION STATEMENT | 2026-04-03 | View → |
| 8-K | CURRENT REPORT | 2026-03-20 | View → |
| 10-K | ANNUAL REPORT | 2026-03-19 | View → |
| 8-K | CURRENT REPORT | 2026-03-09 | View → |
| 424B5 | PROSPECTUS SUPPLEMENT | 2026-01-30 | View → |
| 4 | Insider transaction | 2025-12-16 | View → |
| 4 | Insider transaction | 2025-12-16 | View → |
| 4 | Insider transaction | 2025-12-16 | View → |
| 4 | Insider transaction | 2025-12-16 | View → |
| 4 | Insider transaction | 2025-12-16 | View → |
| 4 | Insider transaction | 2025-12-16 | View → |
| 4 | Insider transaction | 2025-12-16 | View → |
| 8-K | CURRENT REPORT | 2025-12-15 | View → |
| 8-K | CURRENT REPORT | 2025-11-13 | View → |
| 10-Q | QUARTERLY REPORT | 2025-11-13 | View → |
| 4 | Insider transaction | 2025-11-06 | View → |
| 4 | Insider transaction | 2025-11-06 | View → |
| 4 | Insider transaction | 2025-11-06 | View → |
| 4 | Insider transaction | 2025-11-06 | View → |
| 8-K | CURRENT REPORT | 2025-11-05 | View → |
| 424B5 | PROSPECTUS SUPPLEMENT | 2025-11-05 | View → |
| 8-K | CURRENT REPORT | 2025-11-04 | View → |
| 8-K | CURRENT REPORT | 2025-09-17 | View → |
| 8-K | CURRENT REPORT | 2025-09-16 | View → |
| 8-K | CURRENT REPORT | 2025-09-10 | View → |
| 8-K | CURRENT REPORT | 2025-09-02 | View → |
| 4 | Insider transaction | 2025-08-28 | View → |
| 8-K | CURRENT REPORT | 2025-08-07 | View → |
| 10-Q | QUARTERLY REPORT | 2025-08-07 | View → |
| 8-K | CURRENT REPORT | 2025-07-23 | View → |
| 8-K | CURRENT REPORT | 2025-07-10 | View → |
| 4 | Insider transaction | 2025-06-30 | View → |
| 4 | Insider transaction | 2025-06-30 | View → |
Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.
Key Stats
- Last Close
- $4.59
- Market Cap
- $488.55 million
- 52-Week Range
- $0.55 – $8.00
- Average Volume
- 1.42 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.